FBR Capital initiates coverage on Biogen (NASDAQ: BIIB) with a Market Perform. PT $259.00.

Analyst William Tanner, Ph.D comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE